Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
-712,470
Put/Call ratio
72%
SEC-reported price per share
$92.24
Number of holders
255
Value change
-$46,573,724
Number of buys
117
Show 1 more signal
Number of sells
113
Security identity 1 source field
Shares outstanding
65,000,000

Security key

09627Y109

Report period

Q4 2023

Institutions

255

Top holders

10

Ownership snapshot

Top reported holders of BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
255
Shares
64,072,815
Rows available
255
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
217
Q4 2023 holders
255
Holder diff
38
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .